A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients
Clinical trial NCT03570957 · COMPLETED
Trial details
- NCT number
- NCT03570957
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-17
- Primary completion
- 2018-12-27
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.